Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge

Sambit K. Mohanty(Government of Haryana), Anil V. Parwani(The Ohio State University Wexner Medical Center), Sanjay Mukhopadhyay(Cleveland Clinic), Edana Stroberg(Office of Chief Medical Examiner), Alexandar Tzankov(University of Basel), Machita M. Naidu, Dinesh Pradhan, Eric J. Duval(Office of Chief Medical Examiner), Shivani Sharma, Abhishek Satapathy(Sir Ganga Ram Hospital), Lisa M. Barton(Office of Chief Medical Examiner)

Diagnostic Pathology

August 14, 2020

10.1186/s13000-020-01017-8

Cited by 183

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2013|247

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

|Cancer Immunology Research|2019|181